Statistics

Total Visits

Views
Safety of switching from intravenous to subcutaneous rituximab during first-line treatment of patients with non-Hodgkin lymphoma: the Spanish population of the MabRella study53

File Visits

Downloads
41131-1808.pdf12

Select a period of time:

Number of views in the range

Views
Safety of switching from intravenous to subcutaneous rituximab during first-line treatment of patients with non-Hodgkin lymphoma: the Spanish population of the MabRella study37

Number of downloads in the range

Downloads
41131-1808.pdf2

Views

Views
February 20250
March 20257
April 202511
May 20253
June 20250
July 202515
August 20251
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • February 2025
    0
  • March 2025
    0
  • April 2025
    1
  • May 2025
    0
  • June 2025
    0
  • July 2025
    0
  • August 2025
    1
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
Hong Kong10
Singapore7
Brazil7
United States6
Argentina1
Spain1
Ethiopia1
United Kingdom1
Ireland1
Mexico1
 

Top countries by downloads

Downloads
Hong Kong1
United States1
 

Top cities views

Views
Hong Kong10
Atlanta1
Belo Horizonte1
Belém1
Caxambu1
Conceição do Coité1
Council Bluffs1
Dublin1
Forfar1
Fortville1
 

Top cities by downloads

Downloads
Hong Kong1